PubMed:25054547 / 143-324
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-181 | Sentence | denotes | Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 10157 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | MESH:C537417 |
| 10158 | 63-68 | DiseaseOrPhenotypicFeature | denotes | apnea | MESH:D001049 |
| 10159 | 86-102 | ChemicalEntity | denotes | muscle relaxants | |
| 10160 | 104-117 | ChemicalEntity | denotes | suxamethonium | MESH:D013390 |
| 10161 | 121-131 | ChemicalEntity | denotes | mivacurium | MESH:D000077590 |
| 10162 | 136-144 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 10163 | 171-175 | GeneOrGeneProduct | denotes | BCHE | NCBIGene:590 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | 0015270 |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-21 | GeneOrGeneProduct | denotes | Butyrylcholinesterase |
| T4 | 86-92 | GeneOrGeneProduct | denotes | muscle |
| T5 | 171-175 | GeneOrGeneProduct | denotes | BCHE |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 0-21 | GeneOrGeneProduct | denotes | Butyrylcholinesterase |
| T7 | 86-92 | GeneOrGeneProduct | denotes | muscle |
| T8 | 93-102 | GeneOrGeneProduct | denotes | relaxants |
| T9 | 154-163 | GeneOrGeneProduct | denotes | mutations |
| T10 | 171-175 | GeneOrGeneProduct | denotes | BCHE |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T2 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | C537417 |
| T3 | 63-68 | DiseaseOrPhenotypicFeature | denotes | apnea | D001049 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-21 | GeneOrGeneProduct | denotes | Butyrylcholinesterase |
| T3 | 171-175 | GeneOrGeneProduct | denotes | BCHE |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | 0015270 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T2 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | C537417 |
| T3 | 63-68 | DiseaseOrPhenotypicFeature | denotes | apnea | D001049 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T2 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | C537417 |
| T3 | 63-68 | DiseaseOrPhenotypicFeature | denotes | apnea | D001049 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T3 | 0-32 | ChemicalEntity | denotes | Butyrylcholinesterase deficiency | C537417 |
| T4 | 86-102 | ChemicalEntity | denotes | muscle relaxants | ChemicalEntity |
| T5 | 104-117 | ChemicalEntity | denotes | suxamethonium | D013390|http://purl.obolibrary.org/obo/CHEBI_45652 |
| T7 | 121-131 | ChemicalEntity | denotes | mivacurium | D000077590 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 136-144 | OrganismTaxon | denotes | patients |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T7 | 121-131 | ChemicalEntity | denotes | mivacurium | D000077590 | |
| T5 | 104-117 | ChemicalEntity | denotes | suxamethonium | http://purl.obolibrary.org/obo/CHEBI_45652|D013390 | |
| T4 | 86-102 | ChemicalEntity | denotes | muscle relaxants | ChemicalEntity | |
| T3 | 0-32 | ChemicalEntity | denotes | Butyrylcholinesterase deficiency | C537417 | |
| T53614 | 171-175 | GeneOrGeneProduct | denotes | BCHE | ||
| T2 | 0-21 | GeneOrGeneProduct | denotes | Butyrylcholinesterase | ||
| T85129 | 63-68 | DiseaseOrPhenotypicFeature | denotes | apnea | D001049 | |
| T57186 | 0-32 | DiseaseOrPhenotypicFeature | denotes | Butyrylcholinesterase deficiency | C537417 | |
| T32204 | 136-144 | OrganismTaxon | denotes | patients |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T2 | 0-181 | Sentence | denotes | Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene. |
| T2 | 0-181 | Sentence | denotes | Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene. |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 63-68 | HP_0002104 | denotes | apnea |
PubCasesHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 63-68 | HP:0002104 | denotes | apnea |
PubCasesORDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 0-32 | ORDO:132 | denotes | Butyrylcholinesterase deficiency |